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Summary 
In vitro, expression of E-selectin is largely restricted to endothelial cells activated by inflamma- 
tory cytokines. Under activated conditions,  cytokines such as interleukin  (IL)  10,  released by 
keratinocytes in large quantities,  may also increase the expression of E-selectin on the dermal 
microvasculature. The aim of the present study was to investigate the expression of E-selectin 
on cultured human dermal microvascular endothelial  cells  (HDMEC)  isolated from neonatal 
foreskins when exposed to IL-10. Expression of E-selectin was determined by immunofluores- 
cence microscopy, FACS |  analysis,  an HL-60 cell-binding assay, and quantitative polymerase 
chain reaction (PCR)  analysis.  For comparison with large blood vessel cells,  the expression of 
E-selectin on human umbilical vein endothelial cells (HUVEC) was also determined in parallel 
by FACS  |  and  reverse  transcriptase-PCR  analysis  under  identical  conditions.  These  studies 
demonstrate that IL-10 induces the expression of E-selectin on both HDMEC and HUVEC 
and that the level of expression on HDMEC is comparable with that induced by IL-113 and tu- 
mor necrosis factor-0c When HL-60 cells are incubated with HDMEC pretreated with IL-10, 
a consistent increase in adherence  of HL-60 to endothelial  cells  is observed.  This adherence 
was  found  to  be mediated by E-selectin.  PCR  analysis  and  the  quantification  of E-selectin 
cDNA by a novel, highly sensitive and specific PCR-immunoassay demonstrate the induction 
of E-selectin mRNA at the transcriptional level. The induction of the expression of E-selectin 
by IL-10 on HDMEC may provide additional insights into the pathogenic mechanism ofneu- 
trophil accumulation at the site of inflammation in inflammatory skin diseases. 
M 
igration of leukocytes to the site of inflammation is a 
hallmark of an inflammatory response. Multiple lines 
of evidence indicate that increased adherence of circulating 
neutrophils, lymphocytes, and monocytes to the microvas- 
cular endothelium  is an essential early event in the  initia- 
tion  of acute  inflammatory responses,  regularly preceding 
the migration of these cells  through vessel walls and accu- 
mulation at sites of tissue injury (1, 2). Binding of lympho- 
cytes, monocytes/macrophages, and granulocytes to vascu- 
lar  endothelial  cells  is  mediated  by specific  cell  adhesion 
molecules,  a process crucial to the  generation  of immune 
and inflammatory responses (3, 4). 
E-selectin  is  an  endothelial-specific  leukocyte  adhesion 
molecule  expressed on  endothelial  cells  after exposure  to 
inflammatory mediators and is known to be involved in the 
adhesion  of PMN  to  the  endothelium  in  vitro  (5,  6).  In 
vivo, Engelberts et al. (7) found expression of E-selectin on 
endothelial cells in skin biopsies of patients severely ill with 
peritonitis at a distance from the primary inflammatory site. 
Other studies  of septic  shock using cynomolgus monkeys 
also demonstrate a role for E-selectin in the pathogenesis of 
acute inflammation (8).  The cutaneous lymphocyte-associ- 
ated antigen (CLA) is the major T  cell ligand for E-selectin 
and it has been proposed to be involved in the selective tar- 
geting of memory T  cells reactive with skin-associated Ag 
to  cutaneous inflammatory sites  (9).  Santamaria et al.  (10) 
reported a functional linkage between CLA expression and 
disease-associated T  cell effector function in patients with 
atopic demlatitis. E-selectin has also been reported to be a 
major  adhesion  molecule  for the  binding  of adult  T  cell 
leukemia cells  to  endothelial  cells  (11).  These studies  un- 
derscore the critical involvement of E-selectin in inflamma- 
tion. 
Since adhesion of leukocytes to vascular endothelium is 
the first step in their passage from blood into inflammatory 
sites,  cytokines modulating adhesion molecules may regu- 
late  leukocyte  accumulation,  and  hence,  the  nature  and 
progression  of inflammatory responses.  A  series of studies 
have demonstrated  that human  umbilical vein endothelial 
cells (HUVEC) 1 when incubated with IL-113, TNF-ct, and 
LPS, express E-selectin and intercellular adhesion molecule 
1Abbreviations used in this paper: GAPDH, glyceraldehyde-3-phosphate  de- 
hydrogenase; HDMEC, human dermal microvascular endothelial cell; 
HUVEC, human umbilical vein endothelial cell; IA, imrnunoassay; nt, 
nucleotide; RT, reverse  transcriptase. 
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teractions  of endothelial cells with  neutrophils  (3,  4,  13). 
Similarly,  in  cutaneous  diseases,  cell  adhesion  molecules 
expressed by microvascular endothelial cells may contribute 
to the development of vasculitis by providing binding sites 
to leukocytes and lymphocytes. 
IL-10 is a  recently discovered cytokine with  the  ability 
to inhibit cytokine synthesis, T  cell proliferation, and nitric 
oxide formation,  suggesting its immunosuppressive poten- 
tial  (14,  15).  Wogensen  et  al.  (16)  reported recently that 
expression of IL-10 in the islets ofLangerhans oftransgenic 
mice led to a pronounced pancreatic inflammation and vas- 
cular changes such as expression of cell adhesion molecules 
and accumulation of neutrophils and  T  lymphocytes. The 
possible involvement of IL-10 in inflammation was further 
supported by the finding that IL-10 was secreted by kerati- 
nocytes activated by LPS in murine (17) and by UVB light 
in human systems (18).  These observations suggest the im- 
portant regulatory role that IL-10 may have  on other cells 
of the immune system in skin. The direct effects of IL-10, 
however, on a physiologically relevant site such as the der- 
mal  microvasculature,  which  could  explain  how  mono- 
cytes  and  neutrophils  accumulate  in  skin,  have  not  been 
determined. 
The  present study was  carried out  to better understand 
the factors responsible for inflammation in skin. In addition 
to  the known  effects of IL-10  on  monocytes and  T  lym- 
phocytes, we demonstrate here that IL-10 also has the abil- 
ity  to  induce  E-selectin on  human  dermal  microvascular 
endothelial cells (HDMEC).  Identification ofcytokine net- 
works and their mechanism of action may begin to explain 
the  regulatory role  of IL-10  and  other  cytokines  on  skin 
endothelial cells leading to allergic and inflammatory reac- 
tions. Since this is a novel and unexpected finding, the sim- 
ilarities and differences in effect of IL-I 0 is also determined 
on a cell type widely used (HUVEC)  in studies of inflam- 
mation. 
Materials  and Methods 
Isolation and Culture of  HDMEC.  Stable  cultures  of HDMEC 
were established as described previously with the following mod- 
ifications (19). Freshly excised preputial skin from a randomly se- 
lected  anonymous  newborn  was  incubated  in  HBSS,  supple- 
mented with 200 U/ml penicillin and 100 mg/ml streptomycin. 
The outer and inner aspects  of the tissue were mechanically dis- 
sected with a scalpel and were incubated with 1% dispase (Collab- 
orative Research Corp., Bedford, MA) for 5 h at 37~  The epi- 
dermal layer was  separated gently from the dermis and pressure 
was  applied outwardly to  the  remaining dennis  to  extrude mi- 
crovascular endothelial cells.  The  resulting cell suspension  was 
centrifuged for 5 rain at 1,000 g and resuspended in IMDM (Ab- 
bott Laboratories, North Chicago, IL) which was supplemented 
with 200  U/ml penicillin, 100  mg/ml streptomycin, 20 mg/ml 
gentamycin, 2 mM glutamine, 5 ￿  10  4 M dibutyryl 3'5'-cAMP 
(Sigma Chemical Co., St.  Louis, MO),  3.3  ￿  10 .5 M  isobutyl- 
methylxanthine (Sigma Chemical Co.), 8% newborn calf serum 
(Flow  Laboratories, McLean,  VA),  and  2%  human  prepartum 
maternal serum, referred to as complete IMDM, The suspended 
cells  were  then plated onto  35-mm plastic tissue  culture dishes 
(Miles Scientific, Naperville, IL) that had been precoated with 1% 
gelatin. Cultures were expanded when  cells reached confluence. 
Cells were identified as HDMEC by their characteristic morphol- 
ogy and growth pattern as well as by the presence of Factor VIII- 
associated  protein  detected  by  indirect  immunofluorescence. 
Cells in the third passage were used in all assays. Absence of mac- 
rophages was monitored by the failure of cells to express Cl)14. 
HDMEC  cultures that had >1%  contamination with other cell 
Wpes (melanocytes) were not used for functional studies. 
Isolation and Culture of HUVEC.  Primary cultures of HUVEC 
were maintained in Endothelial Cell Growth Medium (both pur- 
chased  from  Clonetics  Corp.,  San  Diego,  CA)  supplemented 
with 2% FCS. Cells in the third passages were used in all experi- 
ments and were free ofmelanocytes and spindle shaped cells. 
HL-60 Cells.  HL-60  cells  (American Type Culture  Collec- 
tion, Bethesda, MD) were cultured in 1KPMI-1640  medium, sup- 
plemented  with  glutamine  (50  mg/ml)  and  10%  FCS.  HL-60 
cells are a continuous human myeloid cell line derived from pe- 
ripheral blood leukocytes of a patient with acute promyelocytic 
leukemia  (20,  21).  Its  characteristics have  been  associated with 
differentiated granulocytes. HL-60  cells were maintained by re- 
placing the  medium  at  3-d  intervals. For the  adherence  assay, 
HL-60 cells were washed and suspended in IMDM with 1% FCS 
at a density of 106 cells/ml. 
Reagents.  Human rlL-10 was purchased from Beckton Dick- 
inson & Co.  (Bedford, MA), rTNF-(x from IK&D Systenls,  Inc. 
(Minneapolis, MN), and rlL-113 from Amersham Corp., (Arling- 
ton Heights, IL).  Both blocking and staining mAb to E-selectin 
were purchased from Amac Inc. (Westbrook, ME). FITC-labeled 
goat anti-rat Ab, BSA, sodium azide, polymyxin B, LPS, goat se- 
rum,  and thimerosal were purchased from Sigma Chemical Co. 
CD15 mAb was purchased from Beckton Dickinson & Co, (San 
Jose,  CA).  The  cytokines were  diluted  in  sterile pyrogen-free 
IMDM. All preparations were reported to be free ofendotoxin in 
bioassays. 
hnmunohistochemistry.  Cytokine-treated HDMEC  were fixed 
with ice-cold methanol and stained with a mAb to E-selectin for 
60 rain at 37~  The cells were washed twice with cold PBS sup- 
plemented with 1% BSA and incubated with a 1:50 dilution of a 
FITC-labeled goat anti-rat Ab (Sigma Chemical Co.) for 30 rain 
at 37~  After two washes with PBS-I% BSA, fluorescence was 
read on  a  fluorescence microscope (Nikon,  Melville, NY).  To 
confirm that  IL-10  was  not  contaminated with  LPS,  HDMEC 
were incubated with 400 t~g/ml ofpolymyxin B (Sigma Chemi- 
cal Co.) along with IL-10, as indicated. 
How Cytometry.  HDMEC were trypsinized and incubated in 
V-bottomed microtiter plates (Flow Laboratories; 105 cells/well) 
with 50 Ixl of primary mAb to E-selectin (Amac Inc.) or mAb to 
CDI5  (Becton  Dickinson &  Co.)  containing  10%  goat serum, 
0.01%  thimerosal and  1%  BSA  for  60  min  at  4~  After two 
washes with PBS containing 0.02 mM sodium azide and 1% BSA, 
the cells were incubated with FITC-conjugated goat anti-rat Ab 
(Sigma Chemical Co.) for 30 rain at 4~  After three washes with 
PBS-1% BSA, the labeled cells were analyzed by flow microfluo- 
rimetry on a FACScan  |  (Becton Dickinson & Co.) within 2 d. 
HL-60 Cell Adherence Assay.  The functional assay for binding 
of HL-60 cells was performed as described (3, 22)  with the fol- 
lowing modifications. HDMEC were plated in complete IMDM 
into  24-well,  8-ram-diameter  tissue  culture  plates  (Falcon)  at 
"~  X  104 cells/well and grown to confluence. Before assay, the 
medium was removed and the HDMEC monolayer washed once 
with  IMDM.  The  monolayers were  incubated with  500  Ixl of 
822  IL-10 Induces E-Selectin on Endothelial Cells complete IMDM containing one of the following cytokines for 4 h 
at 37~  IL-1]3  (10 U/M), TNF-er  (10 ng/ntl or 200 U/ml), or 
IL-10  (200  U/M).  Cytokine-treated  HDMEC  were  incubated 
with the blocking mAb to E-selectin (Amac Inc.) or nonrelevant 
anti-human  IgG at a  concentration  of 10  p,g/ml for 30  min,  as 
indicated.  After incubation,  the  monolayers  were  washed  once 
with serum-free complete IMDM, and 500 btl oflMDM plus 1% 
FCS containing 5  ￿  10  ~ HL  60 cells was added. The monolayers 
were incubated at 37~  for 30 rain in a 5% CO  2 incubator. After 
the  incubation,  the  nonadherent  HL-60  cells were  removed by 
completely filling the well with IMDM plus  1%  FCS,  covering, 
inverting, and  centrifuging at  100 g  for 5  min at 4~  The  me- 
dium  was  removed  and  250  p,1  of 0.5%  crystal  violet in  50% 
methanol was added to each well and incubated at room temper- 
ature  for 15  min. The plates were gently washed in running tap 
water.  For the determination  of bound HL-60 cells, five micro- 
scopic  fields  were  randomly  selected  from  each  well  and  the 
number of bound HL-60 cells was determined by counting. Each 
parameter  was  tested  in  quadruplet  wells.  The  results  were  ex- 
pressed as the number of ilL 60 cells bound per endothelial cell. 
PCR Analysis.  Messenger RNA was isolated from 1.5 ￿  107 
HDMEC  by  the  Oligotex  kit  (Qiagen  Inc.,  Chatsworth,  CA; 
23).  PCR  analysis was carried out using GeneAmp RNA  PCR 
kit (Perkin-Elmer Corp.,  Norwalk,  CT).  250  ng of mRNA was 
reverse  transcribed  using  random  hexamers  as  primer  (Perkin- 
Elmer  Corp.)  and  M-MLV  reverse  transcriptase  (KT)  (Perkin- 
Elmer Corp.) according to the procedure described (24) in a 20-I-d 
reaction.  10 btl RT (equivalent of 500 ng of total RNA) was used 
directly  for  each  amplification  reaction.  Conditions  for  PCR 
were as follows: in a 40-I.L1 reaction, 200 nM of each primer, 250 
mM  each  of dGTP,  dATP,  dCTP,  and  dTTP  (Perkin-Elmer 
Corp.),  50 mM KC1,  20 mM Tris-HC1, pH 8.3, 2.5 mM MgC12, 
100 mg/ml BSA, and 1 U  Taq polymerase (Perkin-Elmer Corp.). 
Primers used were as follows: glyceraldehyde-3-phosphate  dehy- 
drogenase  (GAPDH)  sense  primer  5'-GGGGAGCGAGAT- 
CCCTCCAAAATCAAGTGGGG-3'  (nucleotide  [nt]  51-82) 
and  antisense  primer  5'-GGGTCATGAGTCCTTCCACGA- 
TACCAAAGTTG-3'  (nt  1002-1033)  (25);  E-selectin  sense 
primer 5'-AGCAAGGCATGATGTTAACC-3' (nt 3260-3191) 
and  antisense  primer  5'-GCATTCCTCTCTTCCAGAGC-3' 
(nt  2801-2822)  (26).  For quantitative PCR,  the 5'  end  of anti- 
sense primers  for E-selectin and  GAPDH were biotinylated and 
the 5' end of sense primer was fluoresceinated. 35 rounds of PCR 
were carried out to observe the amplified cDNA on 5% polyacry- 
lanfide  gel.  Sequence data  are  available from EMBL/GenBank/ 
DDBJ  under  accession  numbers  J04038  for  GAPDH  and 
M58017 for E-selectin. 
PCR-lmmunoassay.  Since cDNA is amplified in a  geometric 
progression,  the sensitivi  W of PCR-immunoassay  (IA) is limited 
to  only a  certain  number  of rounds  of amplifications where  the 
amplification  is  a  first  order  reaction  and  the  total  amount  of 
cDNA is linearly related to the concentration ofmRNA. The ex- 
act number  of cycles required for quantitative analysis  is initially 
determined  by  drawing  samples  at  the  end  of each  cycle.  The 
present procedure  included 25 cycles of amplification. Extensive 
washing  followed by filtering with  Centricon  100  filters  (Ami- 
con, Beverly, MA) was carried out to ensure that unbound prim- 
ers that might interfere with the assay were not carried over. The 
assay  for quantitative  analysis,  designated  as  the amplified DNA 
assay, has been described by Holmstrom et al.  (27),  where biotin- 
ylated  amplified  cDNA  is  captured  onto  a  streptavidin-coated, 
96-well microtiter plate  surface.  The  original colorimetric assay 
was modified into a  fluorometric assay.  The fluorescence detec- 
tion was achieved using fluoresceinated primers and endpoint was 
measured on a Fluoroskan (Bio-Rad Laboratories, Hercules, CA). 
Streptavidin-coated  96-well  plates  were  purchased  from  Pierce 
Chemical Co. (Rockford, IL). 
Results 
IL-IO  Induces  E-selectin  on  HDMEC  and  HUVEC. 
FACS  |  analysis  of HDMEC  and  HUVEC  treated  with 
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Figure  1.  Dose-responsive  expression of E-selectin  by [L-IO on HD- 
MEC (A) and HUVEC (B). E-selectin is induced on HDMEC and HU- 
VEC by IL-10 at a concentration  of 100 U/ml. The maximum expression 
occurs  at  200  U/nil concentration.  No  further  increase  is observed  at 
higher concentrations  (500 U/IM). The cells were incubated  with various 
concentrations  oflL-10 (0,  10, 100, 200, and 50() U/ml) for 4 h, stained 
with mAb to E-selectin  and  FITC-conjugated secondary  Ab, and  ana- 
lyzed by FACScan | 
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To determine the cellular location ofE-selectin, immun- 
ofluorescence  microscopy  was  performed  on  HDMEC 
grown on glass coverslips and treated with IL-10 (200 U/ml) 
for 4, 24, and 48 h followed by fluoresceinated staining for 
E-selectin  (Fig.  3).  Untreated  HDMEC  (Fig.  3 A) did not 
show  any  detectable  expression  of  E-selectin,  whereas 
treatment  with  IL-10 for 4  h  resulted  in the  expression  of 
J  the molecule in the perinuclear area as well as in the cyto- 
plasm (Fig.  3  B); treatment  for 24 h  caused distribution  of 
E-selectin  throughout  the  entire  cell  (Fig.  3  C).  Cells 
treated for 48 h  did not show positive staining for E-selec- 
tin (Fig. 3 D). 
Comparison of the Induction of E-selectin Expression by IL-IjS, 
TNF-o6 and IL-IO.  In Fig. 4, the induction of E-selectin 
i  by the  inflammatory cytokines  IL-113,  TNF-o~,  and  IL-10 
on HDMEC  and  HUVEC  is compared.  In HDMEC  (A) 
and HUVEC (B),  all cytokines examined induced E-selec- 
tin expression.  In HDMEC, IL-10 showed maximal induc- 
tion of E-selectin as compared with IL-113 and TNF-c~. In 
HUVEC,  IL-10 was the least effective in inducing expres- 
sion of E-selectin  and a large fraction of HUVEC  did not 
i  express E-selectin after incubation with IL-10. In Fig. 5, it 
is  demonstrated  that  incubation  of HDMEC  with  IL-10, 
together  with  polymyxin B  (400  p~g/ml),  did  not  inhibit 
the ability of IL-10 to induce E-selectin,  whereas the abil- 
ity of LPS to induce E-selectin  was inhibited  in the  pres- 
ence of polymyxin B, indicating that the effect of IL-I  0 on 
HDMEC  was  not  likely  due  to  a  possible  contamination 
with LPS. 
I  IL-IO  Upregulates Adherence of  HL-60  Cells  to  HD- 
MEC.  In Fig. 6, the differences in the adherence of HL- 
60 cells  to untreated (A) and IL-10-treated HDMEC  (B) is 
illustrated.  When untreated  HDMEC  (control) were incu- 
bated  with  HL-60  cells,  few  HL-60  cells  bound  to  the 
monolayer  as  compared  with  incubation  with  IL-10- 
treated  cells.  In  Fig.  7,  quantitative  determination  of the 
adherence  of HL-60 cells  to HDMEC  treated with  IL-113, 
TNF-~, and IL-10 for 4 h is displayed. Significant increases 
in  binding  of HL-60  cells  for all  cytokines  was  observed 
with a maximal increase induced by TNF-~. A neutralizing 
mAb specific for E-selectin reduced the binding of HL-60 
to the  monolayer to  control values  (Fig.  7),  showing that 
the binding of HL-60 cells  to cytokine-activated HDMEC 
was E-selectin specific. Incubation in the presence of a non- 
relevant anti-human IgG did not interfere with the binding 
of ilL-60 ceils  to IL-10-treated HDMEC. 
IL-IO,  IL-1jS,  and  TNF-oe  Induce E-selectin  mRNA  in 
HDMEC and HUVEC.  Using  RT-PCR  analysis  it  was 
found that untreated HDMEC expressed a baseline level of 
E-selectin mP,  NA, whereas HDMEC and HUVEC treated 
with  IL-I[B, TNF-R,  and  IL-10 expressed  higher and  dif- 
ferent levels ofE-selectin nfi~NA (data not shown). In Fig. 8 
the  quantification  of the  expression  of E-selectin  mR.NA 
analyzed  by  PCR.-IA is  shown.  Untreated  HDMEC  and 
HUVEC  showed  a  comparable  baseline  expression  of 
mRNA.  In  HDMEC  treated  with  IL-10,  IL-11B, and 
TNF-ot,  a  significant  increase  in  mP,  NA  was  found.  In 
Figure  2.  Time-dependent induction of E-selectin by IL-10 on H1)- 
MEC (A) and HUVEC (/3). E-selectin is induced by IL-10 on HDMEC 
is after 4 h of treatment, remains elevated for 24 h, and declines to base- 
line levels between 24 and 48 h. The persistence of E-selectin on HI)MEC 
is proportionately higher than on  HUVEC.  The  cells were incubated 
with IL-10 (200 U/ml) for 4, 24, and 48 h, stained with mAb to E-selec- 
tin and FITC-conjugated secondary Ab, and analyzed  by FACScan  | 
increasing  concentrations  of IL-10 (10,  100,  200,  and  500 
U/ml)  for 4  h  demonstrated  that  expression  of E-selectin 
was dose dependent  (Fig.  1, A  and/3).  Maximum expres- 
sion  of E-selectin  on  HDMEC  and  HUVEC  occurred at 
200  U/ml.  Therefore,  this  concentration  was  used  in  all 
subsequent  studies￿9 As shown in Fig.  1, a small population 
of HUVEC  constitutively expresses E-selectin.  Moreover, 
at  200  and  500  U/ml  of IL-10,  another  fraction  of HU- 
VEC fails to express E-selectin.  To further analyze the ki- 
netics  of induction  of E-selectin,  HDMEC  and  HUVEC 
were incubated with IL-10 (200 U/ml) for 4, 24, and 48 h. 
Fig.  2  shows  that  the  kinetics  of maximum  expression  of 
E-selectin  on HDMEC  (A)  and  HUVEC  (B)  occurred at 
4 h  and  declined  after 24 h.  The persistence  of E-selectin 
for 24 h on HDMEC is only slightly higher than that of the 
HUVEC population. 
824  IL-10 Induces E-Selectin  on Endothelial  Cells Figure 3.  Localization  of E-selectin on HDMEC treated with IL-10. HDMEC grown on glass coverslips were treated with IL-10 (200 U/nil) for 0 
(A), 4 (B), 24 (C), and 48 h (D). The untreated cells do not express detectable E-selectin. The expression of E-selectin occurs as early as 4 h and persists 
for at least 24 h. At the end of 48 h, E-selectin cannot be detected. The cells were stained with a primary rnAb to E-selectin and FITC-conjugated sec- 
ondary Ab and analyzed  by fluorescence microscopy. (￿ 
HUVEC, treated either with IL-113 or IL-10, a comparable 
amount ofE-selectin mtLNA was detected and TNF-ci ap- 
peared to be the most potent inducer ofE-selectin mR.NA. 
Discussion 
IL-10 is synthesized by several cell types including kerat- 
inocytes (17), monocytes (28), and T  lymphocytes (29).  In 
skin, IL-10 may play an important role in the cytokine net- 
work  that  determines  the  magnitude  of inflammatory  as 
well  as  other  symptomatic  responses  such  as  allergy.  The 
expression  of E-selectin  on  cytokine-treated  HUVEC  for 
4-6 h suggested an orchestrated response of various cell ad- 
hesion  molecules  in  the  inflammatory process  (3,  4).  The 
persistence of  E-selectin on IL-10-treated HDMEC for 24 h 
suggests the possibility that under physiological conditions, 
IL-10  may  play  a  central  role  in  mediating  immune  and 
nonimmune inflammatory processes. The nonidentical lev- 
els of the E-selectin expression in response to IL-113, IL-10, 
and TNF-ot may be another example of the several differ- 
ences  in  cellular  physiology  between  cells  of the  large 
blood vessels and those from the microvasculature (30-32). 
Other  differences  in  the  expression  of E-selectin  on  HD- 
MEC but not on HUVEC  in response to both  IL-113 and 
TNF-ot have also been recently reported by Sepp et al. (33). 
The  observation  that  the  intensity  of  expression  of 
E-selectin  varies  in  a  given  HDMEC  population  suggests 
that not all endothelial cells respond to stinmli in an identi- 
cal manner.  Since the endothelial  cells  used in these studies 
were isolated from the capillary, arteriolar,  and venular seg- 
ments  of the  skin  microvasculature,  a  uniform  staining  of 
the  population  at  physiological levels  of cytokines  would 
not be  expected.  The  concentrations  of cytokines used  in 
the present studies are believed to be in a normal range and 
able  to  distinguish  between  highly  sensitive  cells,  such  as 
those from the venular segment, from the less sensitive cells 
from the arteriolar segment. 
In the  HUVEC population,  a small  subset  of cells  exists 
that  expresses  E-selectin  constitutively as  demonstrated  by 
both  FACS  |  (Fig.  4  B)  and  tLT-PCR.  (data  not  shown) 
analysis. This could be due to the inherent characteristics of 
a fetal cell population.  When E-selectin cDNA was ampli- 
fied using a  rate limiting number of PCR  cycles and ana- 
lyzed  by  PCR-IA,  differences  in  the  response  to  IL-10 
compared with IL-113 and TNF-ix became evident (Fig. 8). 
Untreated  HDMEC  express the lowest detectable levels of 
E-selectin, a finding consistent with reports from other lab- 
oratories  (3,  4,  13,  30).  It is  of interest  that  IL-10,  IL-113, 
and TNF-ix induce  comparable levels of E-selectin cDNA 
in  HDMEC  (Fig.  8),  whereas  FACS  |  analysis  indicated 
minor variations in the amount of synthesis of E-selectin by 
TNF-ci  (Fig.  4).  E-selectin  mtLNA  levels  in  HUVEC 
treated with  IL-113  and IL-10 are  comparable,  whereas for 
TNF-cx, a significantly higher level of E-selectin mRNA  is 
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Figure 4.  Comparison  of the induction of E-selectin  by IL-113, TNF-c~, 
and IL-10. HDMEC (A) and HUVEC (B) were treated for 4 h with IL-113 
(10 U/ml)>  TNF-e~  (10 ng/ml), and IL-10 (200 U/ml). Cells  were stained 
with mAb to E-selectin  and FITC-conjugated  secondary Ab and analyzed 
by FACScan  | 
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Figure 5.  Effect  ofpolynwxin  B on the ability  oflL-l() to induce  E-selec- 
tin. HDMEC were treated with medium, LPS, LPS in the presence of 
polynwxin B (400 >g/nil), and IL-10 in the presence of polymyxin B. 
Cells were stained  with n'tAb  to E-selectin  and FITC-conjugated  second- 
ary Ab and analyzed  by FACScan  | 
plasm  of keratinocytes in the  basal layers  and  in  the  cell 
membranes of the  Malpighian layer  (36).  T  lymphocytes 
derived from a  Sezary syndrome patient were also immu- 
noreactive  for  IL-10  (36),  and  T  lymphocytes  obtained 
from skin lesions of mucocutaneous and diffuse mucocuta- 
neous forms of American cutaneous leishmaniasis produced 
expressed, a finding consistent with that from other labora- 
tories (3, 4,  13). 
In vivo, E-selectin is expressed by endothelium in aller- 
gic cutaneous inflammation and has been reported to medi- 
ate  the adhesion of eosinophils in vitro  (34,  35).  Whereas 
normal skin  does  not  express  detectable  levels  of IL-10, 
skin injured by tape stripping or by application of a strong 
Ag (e.g., poison ivy) strongly expresses  IL-10 by 18-24 h 
(36).  Fehr et al.  (37)  observed that T  lymphocytes activated 
during the  induction phase  of contact hypersensitivity by 
DNFB  secrete  IL-10  and proliferate  in a  class  II  MHC- 
restricted  manner. The  intradermal injection of a  contact 
allergen that induces IL-113 mRNA also results in the pro- 
duction of IL-10 and the  eventual induction of a primary 
immune response in the skin of BALB/c mice (38). All of 
the above findings suggest that IL-10 may be one of the cy- 
tokines required in the induction phase of allergy. 
In Th2-type inflammatory skin diseases,  IL-10 was iden- 
tified throughout all levels of epidermis and in the  cyto- 
Figure  6.  Adherence of HL-60 cells to cytokine-activated  HI)ME(;. 
Monolayer cultures of untreated HI)MEC (A) and cukures treated with 
IL-10 (100 U/ml) for 4 h (B) were incubated with HL-6i) cells. Only 
treated cells (/7) show binding of ilL-60 cells. (X320). 
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Figure 7.  Quantitative comparison  of adherence of ilL-60 cells to cy- 
tokine-activated  HDMEC. Incubation of HDMEC with IL-I~, TNF-o~, 
and IL-10 increased adherence of HL-60 cells to endothelial cells. HD- 
MEC pretreated for 4 h with control medium, IL-1~ (10 U/nd), TNF-ci 
(I0  ng/ml), and IL-10 (200 U/ml) were incubated with HL-60 cells. 
Blocking  mAb to E-selectin  or nonrelevant  anti-human lgG was added at 
a concentration of 10 Ixg/ml. After removal of nonadherent HL-60 cells, 
the plates were stained  with crystal violet and the number of HL-60 cells 
bound to the endothelial cell monolayer was counted in randomly se- 
lected microscopic fields. Data represent mean +  SD of three experi- 
nlents. 
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Figure 8.  Quantification  ofE-selectin cDNA obtained from HDMEC 
and HUVEC, determined by PCR.-IA. mR.NA was isolated from HD- 
MEC and HUVEC treated with medium, IL-113, TNF-cx,  and IL-10 for 
2 h and analyzed  by P,T-PCR for 25 cycles. The antisense primers for 
E-selectin and GAPDH were biotinylated whereas sense primers were 
fluoresceinated. E-selectin  and GAPDH cDNAs were detected by a fluo- 
rometric analysis  by excitation  at 500 nm and emission  at 520 nm. 
IL-10 mRNA  abundantly (39).  Resident cells in the skin 
rather than infiltrating leukocytes appear to be the  source 
of cytokines that mediate endothelial activation (17, 38). 
In animal models of lupus erythematosis, the onset of the 
disease  was  significantly delayed by the  administration of 
neutralizing  Abs against IL-10 and was increased when IL-10 
was  continuously  administered  (40).  The  induction  of 
E-selectin by IL-10 is likely to contribute to the infiltration 
of cells that express sLex, a ligand for E-selectin, and ulti- 
mately result in damage  to  the  microvasculature in these 
diseases (41). IL-10 has been reported to inhibit chemotac- 
tic  responses of CD4 +  but not CD8 +  T  lymphocytes to- 
wards  IL-8  (42,  43), which might lead to a focusing of T 
lymphocytes in an area of T  lymphocyte activation. These 
mechanisms may begin to explain the specific and continu- 
ous localization ofT lymphocytes in the dermal microenvi- 
ronment in allergic and autoimmune disorders. 
The induction of cell adhesion molecules may also have 
a  therapeutic  potential.  In breast carcinomas treated  with 
intralesional injections of [FN-ol and IFN-% complete or 
partial regressions were associated with activated endothe- 
lium  expressing  HLA-DR,  ICAM-1,  and  infiltration of 
dennis and tumors by T  lymphocytes (44). These observa- 
tions suggest that potentiation of a cell-mediated immuno- 
logical response in neoplastic tissues may help to inhibit tu- 
mor  cell  growth  (44).  Cytokines  such  as  IL-10  that  are 
antiproliferative and induce cell adhesion molecules, may 
play a  role in controlling tumor growth by these mecha- 
nisms. 
Leukocyte recruitment is dependent not only on ligands 
expressed on leukocytes and molecules inducible on endo- 
thelial cells but also on processes active during transendo- 
thelial  migration into  the  extracellutar  spaces.  Since  the 
mechanisms involved are  as  yet unknown, much remains 
to be explored to further our understanding of the fascinat- 
ing but complex interaction of circulating neutrophils and 
the microvascular endothelium during the induction of the 
acute inflammatory response.  IL-10, in addition to its im- 
munoinhibitory properties,  is  a  potent recruitment signal 
for  leukocyte migration in vivo.  It is  possible that  IL-10 
could induce other cell adhesion molecules on HDMEC. 
The ability to isolate HDMEC from 4-ram punch biopsies 
of normal and inflamed skin should make such studies feasi- 
ble (45). 
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